Millennium Management’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
Other funds holding HQL
SCM
PCM
KIM
NIM
FHA
Millennium Management's HQL Position: Q2 2025 in Review
Millennium Management sold out of abrdn Life Sciences Investors (HQL) in Q2 2025, closing a stake of 10,658 shares — an estimated $135K sold.
Millennium Management first reported a position in HQL in Q2 2018 and held it in 14 quarters. The position peaked at $702K in Q4 2022. 75 funds tracked by Wall St. Rank hold HQL as of Q2 2025.
- Millennium Management reported no remaining abrdn Life Sciences Investors position as of Q2 2025 after selling out during the quarter.
- Millennium Management sold 10,658 abrdn Life Sciences Investors shares in Q2 2025, an estimated $135K.
- Millennium Management first reported a position in abrdn Life Sciences Investors in Q2 2018 and held it in 14 quarters.
- Millennium Management's abrdn Life Sciences Investors position peaked at $702K in Q4 2022.
- 75 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2025.
Based on Millennium Management's 13F filing for Q2 2025, filed 14 Aug 2025.